Skip to main content
. Author manuscript; available in PMC: 2019 Jun 19.
Published in final edited form as: Biochemistry. 2018 Apr 6;57(24):3309–3325. doi: 10.1021/acs.biochem.8b00239

Figure 11.

Figure 11

Modulating OvoA reactivity by replacing Y417 using a tyrosine analogue. (A) The active site of the cysteine dioxygenase crystal structure shows the tyrosine–cysteine cross-link, which is mimicked by a tyrosine analogue MtTyr in the OvoA Y417MtTyr variant. (B) Reaction results for wild-type OvoA and the Y417MtTyr variant, suggesting that the OvoA activities can be modulated by replacing Y417 using tyrosine analogues.